C9 and amyotrophic lateral sclerosis: The decreased PML-NB number observed in C9-ALS iPSC-MNs upon arsenite treatment correlated with a significant delay in the disassembly of SGs, compared to GC iPSC-MNs (Fig. 7D, E).